Tech Company Financing Transactions
Tolemy Bio Funding Round
Tolemy Bio, based in Cambridge, raised $1.6 million in funding from Norrsken VC, Big Sur Ventures-Necotium and JME Venture Capital.
Transaction Overview
Company Name
Announced On
5/12/2026
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its data generation, machine learning and engineering capabilities, further develop Orbit, and support its early customer and partner deployments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Kings Hedges Road
Cambridge, CB4 2HY
UK
Cambridge, CB4 2HY
UK
Phone
Undisclosed
Website
Email Address
Overview
At Tolemy Bio, we are building the AI-native control panel for these cell-derived medicines, combining virtual cell models, big biological data, and wet-lab experimentation to help direct cellular systems toward better therapeutic outcomes. Our mission is to make cell biology more predictable, programmable, and scalable. Nature is building tomorrow's medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Ward
Chief Technical Officer
Caelan Anderson
Browse more venture capital transactions:
Prev: 5/12/2026: Rogue Snacks venture capital transaction
Next: 5/12/2026: Vapi venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs